ANN ARBOR, Mich., Jan. 27, 2021 /PRNewswire/ — Swift Biosciences of Ann Arbor, MI has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers. The Swift Normalase® Amplicon SARS-CoV-2 S Gene Panel (SNAP) eliminates the need to perform qPCR for library normalization. A pioneer in the development of DNA and RNA library... Read more
Leader in Next-Generation Sequencing Automation Workflow Solutions Delivers First Turn-key Solution for Whole Genome Sequencing (WGS) of COVID-19 SAN CARLOS, CALIF. (PRWEB) JANUARY 27, 2021 As the COVID-19 virus mutates, so does this growing list of variants, including B.1.1.7., B.1.351 and L452R. These variants, as well as future mutations, can now be identified in real-time by... Read more
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more
MENLO PARK, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its fourth quarter 2020 financial results on Wednesday, February 10, 2021, at 4:30pm Eastern Time.The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.Date: February 10,... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched the Solus One E. coli O157 Pathogen Detection Assay for raw ground beef and raw beef trim. This system is designed for customers who receive a high volume of food samples daily and need a highly sensitive, cost effective assay. The assay is... Read more
Novel media supports automated T-cell expansion to deliver scalable, cost-effective cell therapy treatments Read more
Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021 AUSTIN, Texas, Jan. 27, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter ended December 31, 2020... Read more
26 January 2021 Oxford Instruments Asylum Research is proud to announce that it has joined as a member of the MIT.nano Consortium. This membership is directly aligned with the Oxford Instruments core purpose “to address some of the world’s most pressing challenges.” As part of the membership agreement, Asylum Research has provided MIT.nano with a... Read more
Polen to Succeed Vince Forlenza Effective April 28 FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president, will assume additional responsibility as chairman of the BD board of directors, effective April 28, 2021. Polen will succeed Vincent A. Forlenza, who... Read more